Thermo Fisher Scientific ...

NYSE: TMO · Real-Time Price · USD
488.31
3.27 (0.67%)
At close: Aug 15, 2025, 10:13 AM

Thermo Fisher Scientific Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
4.01B 8.08B 8.52B 4.48B
Short-Term Investments
1.56B n/a n/a n/a
Long-Term Investments
560M 59M 155M 73M
Other Long-Term Assets
2.44B 2.38B 2.22B 3B
Receivables
9.63B 9.66B 9.43B 8.95B
Inventory
4.98B 5.09B 5.63B 5.05B
Other Current Assets
1.96B 1.76B 1.64B 1.64B
Total Current Assets
22.14B 24.59B 25.23B 20.11B
Property-Plant & Equipment
10.79B 11B 10.87B 9.86B
Goodwill & Intangibles
61.39B 60.69B 58.67B 62.07B
Total Long-Term Assets
75.18B 74.14B 71.92B 75.01B
Total Assets
97.32B 98.73B 97.15B 95.12B
Account Payables
3.08B 2.87B 3.38B 2.87B
Deferred Revenue
2.85B 2.69B 2.6B 2.65B
Short-Term Debt
2.48B 3.87B 5.85B 2.8B
Other Current Liabilities
2.94B 2.98B 3.08B 2.68B
Total Current Liabilities
13.33B 14.01B 17.01B 13.44B
Long-Term Debt
29.06B 31.31B 28.91B 32.15B
Other Long-Term Liabilities
1.61B 1.9B 1.75B 2.1B
Total Long-Term Liabilities
34.32B 37.87B 36B 40.71B
Total Liabilities
47.65B 51.88B 53.01B 54.15B
Total Debt
32.77B 36.42B 36.07B 36.34B
Common Stock
444M 442M 441M 439M
Retained Earnings
53.1B 47.36B 41.91B 35.43B
Comprehensive Income
-2.7B -3.22B -3.1B -2.33B
Shareholders Equity
49.58B 46.73B 43.98B 40.79B
Total Investments
2.12B 59M 155M 73M